Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Cardiotoxicity|Antitumor Drugs|Breast Cancer|Trastuzumab
Interventions: DRUG: Trastuzumab
Sponsor: Peking University Third Hospital